The Latin America, Middle East and Africa Gene Synthesis Market is expected to witness market growth of 21.1% CAGR during the forecast period (2021-2027).
An artificial gene is a human-made replacement of the cell-free protein synthesis of double-stranded DNA molecules. This technology is widely used in the biotechnology sector and crucial for synthetic biology. Also, it is a crucial tool that is used in numerous sectors of recombinant DNA technology including gene therapy, molecular engineering, developing vaccines, and heterologous gene expression.
Healthcare technology, connected devices, genomics, artificial intelligence, and big data analytics are the sectors that comprise a broad range of data and insights associated with health. This is a factor that allows the healthcare service providers to deliver diagnoses to the patients in a lesser interval of time as well as enable them to make well-informed decisions about the treatment of patients.
LAMEA is expected to be a really profitable region for the gene synthesis market due to the growing number of studies in the field of synthetic biology and genes in the different countries of the region. South Africa is a country with a significant number of genetic disorders which can be cured with the help of gene synthesis. Also, the significant number of various key players of the pharmaceuticals existing in LAMEA such as Europharma, Mantecorp farmasa, Novartis, and Pfizer, makes LAMEA a significant producer and provider of gene synthesis outputs for rest of the LAMEA.
The Brazil market dominated the LAMEA Gene Synthesis Market by Country 2020, and is expected to continue to be a dominant market till 2027; thereby, achieving a market value of $87.1 million by 2027. The Argentina market is anticipated to grow a CAGR of 21.8% during (2021 - 2027). Additionally, The UAE market is expected to exhibit a CAGR of 20.8% during (2021 - 2027).
Based on Method, the market is segmented into Solid-phase Synthesis, Chip-based Synthesis and PCR-based Enzyme Synthesis. Based on Service Type, the market is segmented into Antibody DNA Synthesis, Viral DNA Synthesis and Others. Based on Application, the market is segmented into Gene & Cell Therapy Development, Vaccine Development, Disease Diagnosis and Others. Based on End User, the market is segmented into Academic & Government Research Institutes, Biotechnology & Pharmaceutical Companies and Contract Research Organizations. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Genscript Biotech Corporation, Thermo Fisher Scientific, Inc., Brooks Automation, Inc., Boster Biological Technology, Twist Bioscience Corporation, Danaher Corporation, Biomatik Corporation, ProteoGenix, ProMab Biotechnologies, Inc., and OriGene Technologies, Inc.
An artificial gene is a human-made replacement of the cell-free protein synthesis of double-stranded DNA molecules. This technology is widely used in the biotechnology sector and crucial for synthetic biology. Also, it is a crucial tool that is used in numerous sectors of recombinant DNA technology including gene therapy, molecular engineering, developing vaccines, and heterologous gene expression.
Healthcare technology, connected devices, genomics, artificial intelligence, and big data analytics are the sectors that comprise a broad range of data and insights associated with health. This is a factor that allows the healthcare service providers to deliver diagnoses to the patients in a lesser interval of time as well as enable them to make well-informed decisions about the treatment of patients.
LAMEA is expected to be a really profitable region for the gene synthesis market due to the growing number of studies in the field of synthetic biology and genes in the different countries of the region. South Africa is a country with a significant number of genetic disorders which can be cured with the help of gene synthesis. Also, the significant number of various key players of the pharmaceuticals existing in LAMEA such as Europharma, Mantecorp farmasa, Novartis, and Pfizer, makes LAMEA a significant producer and provider of gene synthesis outputs for rest of the LAMEA.
The Brazil market dominated the LAMEA Gene Synthesis Market by Country 2020, and is expected to continue to be a dominant market till 2027; thereby, achieving a market value of $87.1 million by 2027. The Argentina market is anticipated to grow a CAGR of 21.8% during (2021 - 2027). Additionally, The UAE market is expected to exhibit a CAGR of 20.8% during (2021 - 2027).
Based on Method, the market is segmented into Solid-phase Synthesis, Chip-based Synthesis and PCR-based Enzyme Synthesis. Based on Service Type, the market is segmented into Antibody DNA Synthesis, Viral DNA Synthesis and Others. Based on Application, the market is segmented into Gene & Cell Therapy Development, Vaccine Development, Disease Diagnosis and Others. Based on End User, the market is segmented into Academic & Government Research Institutes, Biotechnology & Pharmaceutical Companies and Contract Research Organizations. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Genscript Biotech Corporation, Thermo Fisher Scientific, Inc., Brooks Automation, Inc., Boster Biological Technology, Twist Bioscience Corporation, Danaher Corporation, Biomatik Corporation, ProteoGenix, ProMab Biotechnologies, Inc., and OriGene Technologies, Inc.
Scope of the Study
Market Segments Covered in the Report:
By Method
- Solid-phase Synthesis
- Chip-based Synthesis and
- PCR-based Enzyme Synthesis
By Service Type
- Antibody DNA Synthesis
- Viral DNA Synthesis and
- Others
By Application
- Gene & Cell Therapy Development
- Vaccine Development
- Disease Diagnosis and
- Others
By End User
- Academic & Government Research Institutes
- Biotechnology & Pharmaceutical Companies and
- Contract Research Organizations
By Country
- Brazil
- Argentina
- UAE
- Saudi Arabia
- South Africa
- Nigeria
- Rest of LAMEA
Key Market Players
List of Companies Profiled in the Report:
- Genscript Biotech Corporation
- Thermo Fisher Scientific, Inc.
- Brooks Automation, Inc.
- Boster Biological Technology
- Twist Bioscience Corporation
- Danaher Corporation
- Biomatik Corporation
- ProteoGenix
- ProMab Biotechnologies, Inc.
- OriGene Technologies, Inc.
Unique Offerings from the Publisher
- Exhaustive coverage
- The highest number of market tables and figures
- Subscription-based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free
Table of Contents
Chapter 1. Market Scope & Methodology
Chapter 2. Market Overview
Chapter 3. Competition Analysis - Global
Chapter 4. LAMEA Gene Synthesis Market by Method
Chapter 5. LAMEA Gene Synthesis Market by Service Type
Chapter 6. LAMEA Gene Synthesis Market by Application
Chapter 7. LAMEA Gene Synthesis Market by End User
Chapter 8. LAMEA Gene Synthesis Market by Country
Chapter 9. Company Profiles
Companies Mentioned
- Genscript Biotech Corporation
- Thermo Fisher Scientific, Inc.
- Brooks Automation, Inc.
- Boster Biological Technology
- Twist Bioscience Corporation
- Danaher Corporation
- Biomatik Corporation
- ProteoGenix
- ProMab Biotechnologies, Inc.
- OriGene Technologies, Inc.
Methodology
LOADING...
